Long R, Nobert E, Chomyc S, van Embden J, McNamee C, Duran R R, Talbot J, Fanning A
Departments of Medicine, Medical Microbiology, and Surgery, University of Alberta, Edmonton, Alberta, Canada.
Am J Respir Crit Care Med. 1999 Jun;159(6):2014-7. doi: 10.1164/ajrccm.159.6.9809076.
Globally, the proportion of all cases of tuberculosis (TB) caused by drug-resistant strains is increasing. We report the case of a Canadian citizen who acquired a highly drug-resistant strain of Mycobacterium bovis while visiting a relative with AIDS-related tuberculosis in Spain. The origin of the strain was traced using spoligotyping, a polymerase chain reaction (PCR)-based fingerprint technology, and the European DNA database. The level of primary drug resistance-all five first-line drugs and 19 of 21 second-line drugs-in this case was unprecedented in Canada. Isolation of this strain from a Canadian citizen represents the first report of its appearance in this hemisphere. The infection was contained and combined medical-surgical treatment delivered.
在全球范围内,耐药菌株导致的所有结核病病例比例正在上升。我们报告了一名加拿大公民的病例,该公民在西班牙探望一名患有艾滋病相关结核病的亲属时感染了一株高度耐药的牛分枝杆菌。使用间隔寡核苷酸分型法(一种基于聚合酶链反应(PCR)的指纹技术)和欧洲DNA数据库追踪了该菌株的来源。该病例中对所有一线药物以及21种二线药物中的19种的原发性耐药水平在加拿大是前所未有的。从一名加拿大公民身上分离出这种菌株代表了该菌株在西半球出现的首次报告。感染得到了控制,并进行了联合药物和手术治疗。